Dai T, Xu Z, Wang H, Han W, et al. Pharmacokinetics, safety, and efficacy of fuzuloparib in combination with abiraterone acetate and prednisone in patients with metastatic castration-resistant prostate cancer: a phase 1 dose escalation and expansion study. BMC Cancer 2026 Jun 25. doi: 10.1186/s12885-026-16182.
PMID: 42351007